Literature DB >> 16225077

Poisonings resulting from the ingestion of magic mushrooms in Kraków.

Leszek Satora1, Halina Goszcz, Krzysztof Ciszowski.   

Abstract

Hallucinogenic mushrooms, also called "magic mushrooms", are becoming a more frequent cause of abuse, especially among young people, who use them experimentally for recreational purposes. In the autumn of 2004, several people were admitted to and observed in the Department of Clinical Toxicology in Krakòw after they had used magic mushrooms to experience hallucinatory sensations. Three of them had visual hallucinations, and the fourth experienced both visual and auditory hallucinations followed by the exogenous psychosis after use of Psilocybe semilanceata. One person was hospitalised for several days while the others were observed in the emergency department. The main source of information for patients about hallucinogenic mushrooms was the internet. In the cases discussed the mushroom poisoning caused no organ damage and the symptoms disappeared in about 6 hours.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16225077

Source DB:  PubMed          Journal:  Przegl Lek        ISSN: 0033-2240


  4 in total

Review 1.  Mycetism: a review of the recent literature.

Authors:  Kimberlie A Graeme
Journal:  J Med Toxicol       Date:  2014-06

2.  Peculiar plants and fantastic fungi: An ethnobotanical study of the use of hallucinogenic plants and mushrooms in Slovenia.

Authors:  Karsten Fatur
Journal:  PLoS One       Date:  2021-01-07       Impact factor: 3.240

3.  Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms.

Authors:  Emma I Kopra; Jason A Ferris; Adam R Winstock; Allan H Young; James J Rucker
Journal:  J Psychopharmacol       Date:  2022-04-07       Impact factor: 4.562

4.  Self-reported negative outcomes of psilocybin users: A quantitative textual analysis.

Authors:  Bheatrix Bienemann; Nina Stamato Ruschel; Maria Luiza Campos; Marco Aurélio Negreiros; Daniel C Mograbi
Journal:  PLoS One       Date:  2020-02-21       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.